Trade

with

Apricus Biosciences Inc
(NASDAQ: APRI)
AdChoices
=
1.64
0.00
0.00%
After Hours :
1.56
-0.08
-4.88%

Open

1.91

Previous Close

1.64

Volume (Avg)

399.62k (150.52k)

Day's Range

1.47-1.96

52Wk Range

1.12-2.71

Market Cap.

62.49M

Dividend Rate ( Yield )

-

Beta

2.42

Shares Outstanding

38.10M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 2.51M

    • Net Income

    • -16.94M

    • Market Cap.

    • 62.49M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -97.79

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.42

    • Forward P/E

    • -6.19

    • Price/Sales

    • 10.55

    • Price/Book Value

    • 5.27

    • Price/Cash flow

    • -7.33

      • EBITDA

      • -17.29M

      • Return on Capital %

      • -24.21

      • Return on Equity %

      • -45.29

      • Return on Assets %

      • -24.21

      • Book Value/Share

      • 0.31

      • Shares Outstanding

      • 38.10M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 4.17

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 357.60

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • -15.87

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 97.38

            • 64.72

            • Pre-Tax Margin

            • -117.92

            • 13.77

            • Net Profit Margin

            • -97.79

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 40.60

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -611.40

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -633.00

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.33

              • Current Ratio

              • 2.70

              • 1.52

              • Quick Ratio

              • 2.51

              • 0.87

              • Interest Coverage

              • -

              • 6.77

              • Leverage Ratio

              • 1.71

              • 1.91

              • Book Value/Share

              • 0.31

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -8.95

                • 63.29

                • P/E Ratio 5-Year High

                • -68.66

                • 237.47

                • P/E Ratio 5-Year Low

                • -6.11

                • 19.71

                • Price/Sales Ratio

                • 10.55

                • 3.53

                • Price/Book Value

                • 5.27

                • 3.31

                • Price/Cash Flow Ratio

                • -7.33

                • 21.23

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -45.29

                        (-579.00)

                      • 7.86

                        (9.58)

                      • Return on Assets %

                        (5-Year Average)

                      • -24.21

                        (-139.30)

                      • 4.14

                        (5.54)

                      • Return on Capital %

                        (5-Year Average)

                      • -41.07

                        (-237.80)

                      • 5.59

                        (7.66)

                      • Income/Employee

                      • -

                      • 27.79k

                      • Inventory Turnover

                      • 0.47

                      • 1.80

                      • Asset Turnover

                      • 0.25

                      • 0.38

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -17.37M
                      Operating Margin
                      -691.64
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -7.33
                      Ownership

                      Institutional Ownership

                      8.35%

                      Top 10 Institutions

                      7.76%

                      Mutual Fund Ownership

                      4.06%

                      Float

                      99.18%

                      5% / Insider Ownership

                      31.26%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Total Stock Mkt Idx

                      •  

                        654,162

                      • 0.00

                      • 1.72

                      • Vanguard Extended Market Index Fund

                      •  

                        335,016

                      • 2.37

                      • 0.88

                      • Vanguard Instl Total Stock Market Index

                      •  

                        120,161

                      • 0.00

                      • 0.32

                      • iShares Micro-Cap

                      •  

                        115,196

                      • 0.00

                      • 0.33

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        103,681

                      • 0.00

                      • 0.27

                      • Symphonia Azionario USA

                      •  

                        36,113

                      • 0.00

                      • 0.09

                      • Vanguard Balanced Index Fund

                      •  

                        31,988

                      • 0.00

                      • 0.08

                      • Fidelity Spartan® Total Market Idx Fund

                      •  

                        18,211

                      • 0.00

                      • 0.05

                      • STAAR Smaller Company Stock Fund

                      •  

                        15,500

                      • 19.23

                      • 0.04

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Group, Inc.

                      •  

                        1,121,465

                      • 0.00%

                      • 2.94

                      • Visium Asset Management LLC

                      •  

                        1,102,000

                      • 0.00%

                      • 2.89

                      • California Public Employees Retrmnt Sys

                      •  

                        258,130

                      • 0.00%

                      • 0.68

                      • Geode Capital Management, LLC

                      •  

                        126,400

                      • -0.07%

                      • 0.33

                      • BlackRock Fund Advisors

                      •  

                        123,560

                      • +2.94%

                      • 0.32

                      • Northern Trust Investments, N.A.

                      •  

                        63,256

                      • -2.31%

                      • 0.17

                      • BNY Mellon Asset Management Ltd.

                      •  

                        50,232

                      • +1.43%

                      • 0.13

                      • Symphonia SGR S.p.A.

                      •  

                        36,113

                      • 0.00%

                      • 0.09

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Specific & Generic

                      Type

                      Distressed

                      Style

                      Small Core

                      Apricus Biosciences, Inc., was incorporated in Nevada in 1987. It is a pharmaceutical company, that develops and commercializes pharmaceutical products that treat large patient populations with operations based in the United States. ...moreIts products have been developed utilizing its NexACT proprietary permeation enhancement technology. Its initial approved product is Vitaros approved in Canada for the treatment of erectile dysfunction (ED) and its next in-line late stage product candidate is Femprox for the treatment of female sexual arousal disorder (FSAD). It has also filed for approval of Vitaros for the treatment of ED in Europe through the Decentralized Approval Process (DCP) and in Switzerland. Femprox has completed one Phase III clinical trial in China and the Company is developing a regulatory s...moreubmission plan for additional clinical trials in the U.S., Canada and Europe. The Company operates in a single segment, through which it design and develop pharmaceutical products with our NexACT platform. On December 14, 2009, the Company acquired Bio-Quant, Inc. (Bio-Quant), a specialty biotech contract research organization (CRO) based in San Diego, California. It own an approximate total of 83 registered trademarks as well as 65 pending trademark applications and 5 allowed pending trademark applications worldwide. It owns registered trademarks for Vitaros, Femprox and NexACT in certain countries and territories.lessless

                      Key People

                      Richard W. Pascoe

                      CEO/Director

                      Dr. Kleanthis G. Xanthopoulos,PhD

                      Chairman of the Board/Director

                      Steven Martin

                      CFO/Chief Accounting Officer/Senior VP/Secretary

                      Mr. Edward Cox

                      Vice President, Divisional

                      Dr. Wendell D. Wierenga,PhD

                      Director

                      • Apricus Biosciences Inc

                      • 11975 El Camino Real

                      • San Diego, CA 92130

                      • USA.Map

                      • Phone: +1 858 222-8041

                      • Fax: +1 858 436-8155

                      • apricusbio.com

                      Incorporated

                      1987

                      Employees

                      21

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: